Ivan J. Fuss

22.9k total citations · 12 hit papers
120 papers, 18.3k citations indexed

About

Ivan J. Fuss is a scholar working on Immunology, Genetics and Surgery. According to data from OpenAlex, Ivan J. Fuss has authored 120 papers receiving a total of 18.3k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Immunology, 41 papers in Genetics and 25 papers in Surgery. Recurrent topics in Ivan J. Fuss's work include Inflammatory Bowel Disease (38 papers), Immune Cell Function and Interaction (31 papers) and IL-33, ST2, and ILC Pathways (28 papers). Ivan J. Fuss is often cited by papers focused on Inflammatory Bowel Disease (38 papers), Immune Cell Function and Interaction (31 papers) and IL-33, ST2, and ILC Pathways (28 papers). Ivan J. Fuss collaborates with scholars based in United States, Germany and Japan. Ivan J. Fuss's co-authors include Warren Strober, Atsushi Kitani, Richard S. Blumberg, Markus F. Neurath, Peter Mannon, Monica Boirivant, Brian L. Kelsall, Frank Heller, MF Neurath and E. Stüber and has published in prestigious journals such as Nature, New England Journal of Medicine and Journal of Biological Chemistry.

In The Last Decade

Ivan J. Fuss

118 papers receiving 17.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antibodies to interleukin 12 abrogate established experimental colitis in mice.

1995 1.2k citations MF Neurath, Ivan J. Fuss et al. The Journal of Experimental Medicine profile →
The Immunology of Mucosal Models of Inflammation

2002 1.1k citations Warren Strober, Ivan J. Fuss et al. profile →
The fundamental basis of inflammatory bowel disease

2007 1.0k citations Warren Strober, Ivan J. Fuss et al. Journal of Clinical Investigation profile →
Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn’s disease LP cells manifest increased secretion of IFN-γ, whereas ulcerative colitis LP cells manifest increased secretion of IL-5

1996 1.0k citations Ivan J. Fuss, Markus F. Neurath et al. The Journal of Immunology profile →
Proinflammatory Cytokines in the Pathogenesis of Inflammatory Bowel Diseases

2011 897 citations Warren Strober, Ivan J. Fuss profile →
Interleukin-13 Is the Key Effector Th2 Cytokine in Ulcerative Colitis That Affects Epithelial Tight Junctions, Apoptosis, and Cell Restitution

2005 855 citations Frank Heller, Ivan J. Fuss et al. profile →
Anti–Interleukin-12 Antibody for Active Crohn's Disease

2004 628 citations Peter Mannon, Ivan J. Fuss et al. profile →
Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis

2004 600 citations Ivan J. Fuss, Frank Heller et al. Journal of Clinical Investigation profile →
Cutting Edge: Regulatory T Cells Induce CD4+CD25−Foxp3− T Cells or Are Self-Induced to Become Th17 Cells in the Absence of Exogenous TGF-β

2007 591 citations Lili Xu, Atsushi Kitani et al. The Journal of Immunology profile →
TGF-β1 Plays an Important Role in the Mechanism of CD4+CD25+ Regulatory T Cell Activity in Both Humans and Mice

2004 525 citations Atsushi Kitani, Ivan J. Fuss et al. The Journal of Immunology profile →
Oxazolone Colitis, a Th2 Colitis Model Resembling Ulcerative Colitis, Is Mediated by IL-13-Producing NK-T Cells

2002 522 citations Frank Heller, Ivan J. Fuss et al. Immunity profile →
Experimental Models of Inflammatory Bowel Diseases

2015 502 citations Ivan J. Fuss, Warren Strober et al. profile →

Peers

Countries citing papers authored by Ivan J. Fuss

Since Specialization

Citations

This map shows the geographic impact of Ivan J. Fuss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan J. Fuss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan J. Fuss more than expected).

Fields of papers citing papers by Ivan J. Fuss

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivan J. Fuss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan J. Fuss. The network helps show where Ivan J. Fuss may publish in the future.

Co-authorship network of co-authors of Ivan J. Fuss

This figure shows the co-authorship network connecting the top 25 collaborators of Ivan J. Fuss. A scholar is included among the top collaborators of Ivan J. Fuss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivan J. Fuss. Ivan J. Fuss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Navigating the Complexities of Common Variable Immunodeficiency Enteropathy 2025 ·Immunology and Allergy Clinics of North America ·Joud Hajjar, Atiq Ur Rehman, (unknown), Ivan J. Fuss	0
2	Development of hepatic fibrosis in common variable immunodeficiency‐related porto‐sinusoidal vascular disorder 2024 ·Alimentary Pharmacology & Therapeutics ·Julian Hercun, (unknown), Anusha Vittal, (unknown), (unknown), Jenna Bergerson, Steven M. Holland, Gülbû Uzel, Warren Strober, Ivan J. Fuss, Christopher Koh, David E. Kleiner, Theo Heller	1
3	Prospective evaluation of patients with non‐cirrhotic portal hypertension: A single centre study 2024 ·Alimentary Pharmacology & Therapeutics ·(unknown), (unknown), (unknown), (unknown), (unknown), Ivan J. Fuss, Jenna Bergerson, (unknown), Jacqueline Laurin, (unknown), (unknown), Julian Hercun, Bernadette Redd, David E. Kleiner, Christopher Koh, Theo Heller	2
4	Blau syndrome NOD2 mutations result in loss of NOD2 cross-regulatory function 2022 ·Frontiers in Immunology ·Liming Mao, (unknown), Guangxun Meng, Ivan J. Fuss, (unknown), Zhiqiong Yang, Qiuyun Xu, Atsushi Kitani, Warren Strober	24
5	The Role of NLRP3 and IL-1β in the Pathogenesis of Inflammatory Bowel Disease 2018 ·Frontiers in Immunology ·Liming Mao, Atsushi Kitani, Warren Strober, Ivan J. Fuss	188
6	CVID enteropathy is characterized by exceeding low mucosal IgA levels and interferon-driven inflammation possibly related to the presence of a pathobiont 2018 ·Clinical Immunology ·Natalia Shulzhenko, Xiaoxi Dong, (unknown), Renee L. Greer, Manoj Gurung, Stephany Vasquez‐Perez, Ekaterina Peremyslova, Stanislav V. Sosnovtsev, Martha Quezado, Michael Yao, (unknown), Warren Strober, Ivan J. Fuss, Andrey Morgun	51
7	Akkermansia muciniphila mediates negative effects of IFNγ on glucose metabolism 2016 ·Nature Communications ·Renee L. Greer, Xiaoxi Dong, Ana Carolina Franco de Moraes, Ryszard A. Zielke, Gabriel da Rocha Fernandes, Ekaterina Peremyslova, Stephany Vasquez‐Perez, Alexi A. Schoenborn, Everton Padilha Gomes, Alexandre C. Pereira, Sandra Roberta G. Ferreira, Michael Yao, Ivan J. Fuss, Warren Strober, Aleksandra E. Sikora, Gregory A. Taylor, Ajay Gulati, Andrey Morgun, Natalia Shulzhenko	220
8	IL-13Rα2-bearing, type II NKT cells reactive to sulfatide self-antigen populate the mucosa of ulcerative colitis 2014 ·Gut ·Ivan J. Fuss, Bharat Joshi, Zhiqiong Yang, Heba Degheidy, Stefan Fichtner‐Feigl, Heitor Siffert Pereira de Souza, Florian Rieder, Franco Scaldaferri, Anja Schirbel, Melania Scarpa, Gail West, (unknown), Lili Xu, Pamela Leland, Michael Yao, Peter Mannon, Raj K. Puri, Claudio Fiocchi, Warren Strober	65
9	Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis 2008 ·Journal of Clinical Investigation ·Tomohiro Watanabe, Naoki Asano, Peter J. Murray, Keiko Ozato, Prafullakumar Tailor, Ivan J. Fuss, Atsushi Kitani, Warren Strober	279
10	Induction of IL-13 Triggers TGF-β1-Dependent Tissue Fibrosis in Chronic 2,4,6-Trinitrobenzene Sulfonic Acid Colitis 2007 ·The Journal of Immunology ·Stefan Fichtner‐Feigl, Ivan J. Fuss, Cheryl Young, Tomohiro Watanabe, Edward K. Geissler, Hans J. Schlitt, Atsushi Kitani, Warren Strober	177
11	The fundamental basis of inflammatory bowel disease breakdown → 2007 ·Journal of Clinical Investigation ·Warren Strober, Ivan J. Fuss, Peter Mannon	1047
12	Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis breakdown → 2004 ·Journal of Clinical Investigation ·Ivan J. Fuss, Frank Heller, Monica Boirivant, Francisco León, Masaru Yoshida, Stefan Fichtner‐Feigl, Zhiqiong Yang, Mark A. Exley, Atsushi Kitani, Richard S. Blumberg, Peter Mannon, Warren Strober	600
13	Natural Killer T Cells in Mucosal Homeostasis 2004 ·Annals of the New York Academy of Sciences ·Arthur Kaser, Edward E. S. Nieuwenhuis, Warren Strober, Lloyd Mayer, Ivan J. Fuss, Sean P. Colgan, Richard S. Blumberg	9
14	The Interrelated Roles of TGF-β and IL-10 in the Regulation of Experimental Colitis 2002 ·The Journal of Immunology ·Ivan J. Fuss, Monica Boirivant, Brian E. Lacy, Warren Strober	227
15	An Enteric Helminth Infection Protects Against an Allergic Response to Dietary Antigen 2002 ·The Journal of Immunology ·Mohamed Elfatih H. Bashir, Peter S. Andersen, Ivan J. Fuss, Hai Ning Shi, Cathryn Nagler‐Anderson	190
16	Oxazolone Colitis, a Th2 Colitis Model Resembling Ulcerative Colitis, Is Mediated by IL-13-Producing NK-T Cells breakdown → 2002 ·Immunity ·Frank Heller, Ivan J. Fuss, Edward E. S. Nieuwenhuis, Richard S. Blumberg, Warren Strober	522
17	Oral Administration of Recombinant Cholera Toxin Subunit B Inhibits IL-12-Mediated Murine Experimental (Trinitrobenzene Sulfonic Acid) Colitis 2001 ·The Journal of Immunology ·Monica Boirivant, Ivan J. Fuss, (unknown), (unknown), Warren Strober	45
18	TNBS-Colitis 2000 ·International Reviews of Immunology ·Markus F. Neurath, Ivan J. Fuss, Warren Strober	167
19	Intestinal lymphangiectasia, a disease characterized by selective loss of naive CD45RA+ lymphocytes into the gastrointestinal tract 1998 ·European Journal of Immunology ·Ivan J. Fuss, Warren Strober, Brenda A. Cuccherini, (unknown), Xavier Bossuyt, (unknown), Thomas A. Fleisher, Kevin Horgan	48
20	Antibodies to interleukin 12 abrogate established experimental colitis in mice. breakdown → 1995 ·The Journal of Experimental Medicine ·MF Neurath, Ivan J. Fuss, Brian L. Kelsall, E. Stüber, Warren Strober	1151

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact